Prepregnancy body mass index and congenital heart defects among offspring: a population-based study

Nicolas L Madsen1, Stephen M Schwartz, Mark B Lewin

  • 1Department of Pediatrics, Division of Pediatric Cardiology, University of Washington, Seattle, WA, USA. nicolas.madsen@cchmc.org

Congenital Heart Disease
|September 13, 2012
PubMed

Insights

Maternal obesity increases the risk of congenital heart defects (CHD) in infants. Higher maternal body mass index (BMI) correlated with a greater likelihood of CHD, particularly outflow tract defects.

Area of Science:

  • Reproductive Health
  • Pediatric Cardiology
  • Public Health

Background:

  • Maternal obesity is a known risk factor for birth defects.
  • The specific link between maternal obesity and congenital heart defects (CHD) requires further elucidation.

Purpose of the Study:

  • To investigate the association between maternal prepregnancy body mass index (BMI) and the development of fetal congenital heart defects (CHD).
  • To conduct the largest population-based case-control study to date on this topic.

Main Methods:

  • A case-control study utilized linked birth-hospital discharge records from Washington State (1992-2007).
  • Infants with CHD (n=14,142) were identified via ICD-9-CM codes; 141,420 controls were randomly selected.
  • Maternal prepregnancy BMI was calculated, and odds ratios (OR) were adjusted for gestational diabetes.

Main Results:

  • Infants with CHD were more likely to have obese mothers (OR 1.22).
  • Risk increased with higher BMI categories (e.g., BMI ≥ 40: OR 1.49).
  • Left and right ventricular outflow tract defects showed the strongest associations (ORs 1.27 and 1.43, respectively). Hypoplastic left heart syndrome was markedly associated (OR 1.86).

Conclusions:

  • Confirmed association between maternal obesity and CHD, with risk escalating with increasing BMI.
  • Outflow tract defects appear uniquely associated with maternal obesity.
  • Maternal obesity poses a significant risk for offspring CHD, necessitating targeted management strategies.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...